Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
/in Dendritic Cells, Hypernephroma, International Publications, Prostate Cancer /von 2011-04-20 / PLoS ONE 2011 Apr;6(4):e18801Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
/in International Publications, Newcastle Disease Virus /von 2011-04-06 / J. Virol. 2011 Jun;85(12):6015-23Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
/in Dendritic Cells, International Publications /von 2011-04-05 / Mol. Ther. 2011 Aug;19(8):1558-68Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-04-01 / Immunotherapy 2011 Apr;3(4):569-76Dendritic cells and cutaneous T-cell lymphomas
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-13Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
/in Breast Cancer, Hyperthermia, International Publications /von 2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-9Third generation dendritic cell vaccines for tumor immunotherapy
/in Dendritic Cells, International Publications /von 2011-03-25 / Eur. J. Cell Biol. 2012 Jan;91(1):53-8Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de